Showing results (241-250 of 392) with videos related to
Sort By:
Pageof 40
Cancer Discovery|December 21, 2013
Evolution of DNA methylation is linked to genetic aberrations in chronic lymphocytic leukemiaChristopher C Oakes, Rainer Claus, Lei Gu, et al.Blood Advances|June 9, 2026
PLCG2 Exon-Skipped Variants: Insights into Their Potential Role in Chronic Lymphocytic LeukemiaJialei Qi, Wen Li, Rashmi Priyadharshini Dheenadayalan, et al.Blood|April 24, 2019
IGF1R as druggable target mediating PI3K-δ inhibitor resistance in a murine model of chronic lymphocytic leukemiaAnnika Scheffold, Billy Michael Chelliah Jebaraj, Eugen Tausch, et al.Science Translational Medicine|January 17, 2020
Stromal cell protein kinase C-β inhibition enhances chemosensitivity in B cell malignancies and overcomes drug resistanceEugene Park, Jingyu Chen, Andrew Moore, et al.Blood|May 27, 2016
Complex karyotypes and KRAS and POT1 mutations impact outcome in CLL after chlorambucil-based chemotherapy or chemoimmunotherapyCarmen Diana Herling, Marion Klaumünzer, Cristiano Krings Rocha, et al.Science Immunology|July 30, 2017
Tumor-derived exosomes modulate PD-L1 expression in monocytesFranziska Haderk, Ralph Schulz, Murat Iskar, et al.Blood|June 30, 2023
Detailed safety profile of acalabrutinib vs ibrutinib in previously treated chronic lymphocytic leukemia in the ELEVATE-RR trialJohn F Seymour, John C Byrd, Paolo Ghia, et al.Blood|July 17, 2009
First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemiaBarbara F Eichhorst, Raymonde Busch, Stephan Stilgenbauer, et al.Blood|April 27, 2019
Efficacy of venetoclax in relapsed chronic lymphocytic leukemia is influenced by disease and response variablesAndrew W Roberts, Shuo Ma, Thomas J Kipps, et al.European Journal of Immunology|March 31, 2021
Increased B-cell activity with consumption of activated monocytes in severe COVID-19 patientsIgor Kos, Benedikt Balensiefer, Vadim Lesan, et al.Pageof 40